Highly Sensitive and Accurate Assessment of Minimal Residual Disease in Chronic Lymphocytic Leukemia Using the Novel CD160-ROR1 Assay

por Farren, Timothy W., Sadanand, Kaushik S., Agrawal, Samir G.
Publicado 2020

STAT3 and NF-κB cooperatively control in vitro spontaneous apoptosis and poor chemo-responsiveness in patients with chronic lymphocytic leukemia

por Liu, Feng-Ting, Jia, Li, Wang, Ping, Wang, Huaqing, Farren, Timothy W., Agrawal, Samir G.
Publicado 2016

Minimal residual disease detection with tumor-specific CD160 correlates with event-free survival in chronic lymphocytic leukemia

por Farren, T W, Giustiniani, J, Fanous, M, Liu, F, Macey, M G, Wright, F, Prentice, A, Nathwani, A, Agrawal, S G
Publicado 2015